According to MeiraGTx's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 22.9388. At the end of 2023 the company had a P/S ratio of 31.9.
Year | P/S ratio | Change |
---|---|---|
2023 | 31.9 | 60.43% |
2022 | 19.9 | -29.06% |
2021 | 28.0 | -34.89% |
2020 | 43.0 | -22.43% |
2019 | 55.4 | |
2018 | N/A |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
Organovo ONVO | 48.5 | 111.36% | ๐บ๐ธ USA |
Orchard Therapeutics
ORTX | 17.4 | -24.12% | ๐ฌ๐ง UK |
Novavax NVAX | 0.9982 | -95.65% | ๐บ๐ธ USA |
Novocure
NVCR | 3.12 | -86.39% | Jersey |